Now showing items 1-3 of 3
The long view on COVID-19 theranostics and oral antivirals: living with endemic disease and lessons from molnupiravir
The long view on living with COVID-19 as an endemic disease calls for expanding the planetary health inter-vention toolbox. We will need a battery of vaccines, small molecule oral antiviral drugs, and biomarkers toforecast ...
Tixagevimab and cilgavimab: Can we see more recommendations for monoclonal antibodies beyond COVID-19 vaccination
(Cambridge University Press, 2022)
Nearly three years after its detection, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome CoV-2, is still a life-threatening global pandemic health disease that contributed to a high ...
Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation
(Taylor and Francis, 2022)
Background: The aim of this study was to provide a scoping and comprehensive review for the clinical outcomes from the cross-link of Type 2 diabetes mellitus (T2DM), COVID-19, and sarcopenia. Methods: By using PRISMA ...